What if they could test the drug on YOUR cancer before treating you?
This is one I find genuinely exciting and I wanted to share it here.
We have all been there for treatment of one thing or another, not necessarily cancer, but other things where the doctor tries one medicine to see how we react to it. It is not their fault, everyone is different and we all react differently to things. Trial and error is all there was before now.
A systematic review published in April 2026 and then mentioned in Science Direct and UroToday May 2026, looked at patient-derived organoids - lab-grown, three-dimensional models made from a man's own prostate cancer cells. The review confirmed these models are advancing toward clinical use for treatment selection.
The practical implication is significant: these mini-tumours are close enough to the real thing that researchers can test which drugs work on them before any drug is given to the patient. The idea of personalised treatment - matching the therapy to the specific biology of that man's cancer rather than working through a standard sequence - moves much closer to reality.
We are not at a point where this is standard clinical practice. I want to be clear about that.
But I share it because I think this community deserves to know where the science is headed. The years of uncertainty - will this treatment work? why did the last one not? - may eventually be addressable before treatment begins rather than after.
Has anyone in this community had genomic or molecular testing done to guide their treatment choices? I am curious how many people are already having this conversation with their doctors.
0
0 comments
Alex Beviss
3
What if they could test the drug on YOUR cancer before treating you?
powered by
Prostate Paladin
skool.com/prostate-paladin-4886
Prostate awareness for men and women. The prostate does not belong in the shadows with no understanding. Awareness is the key.
Build your own community
Bring people together around your passion and get paid.
Powered by